[China Biologic to Attend the 35th Annual J.P. Morgan Healthcare Conference —Reiterates Full Year 2016 Financial Forecast— BEIJING, China – January 4, 2017 – For additional information or interest in meeting with management, please contact your J.P. Morgan institutional sales representative. About Ch]
[China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement HONG KONG, China, January 4 , 2017 - China Cord Blood Corporation In connection with the Share Purchase Agreement, other pending share sale arrangements entered into by Golden Meditech and Nanjing Xinjiekou Departm]
[China Biologic to Attend the 35th Annual J.P. Morgan Healthcare Conference —Reiterates Full Year 2016 Financial Forecast— BEIJING, China – January 4, 2017 – For additional information or interest in meeting with management, please contact your J.P. Morgan institutional sales representative. About Ch]
[CONFIDENTIAL EXECUTION VERSION SECURITIES PURCHASE AGREEMENT Agreement Company Purchaser This Securities Purchase Agreement (this “ WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase ]
[CONFIDENTIAL EXECUTION VERSION SECURITIES PURCHASE AGREEMENT Agreement Company Purchaser This Securities Purchase Agreement (this “ WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase ]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .For]
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .For]
[Execution Version SHARE REPURCHASE AGREEMENT Agreement This Share Repurchase Agreement (this (i) Company (ii) Selling Shareholder Party Parties Each of the parties listed above shall be referred to herein individually as a RECITALS WHEREAS SHA WITNESSETH NOW, THEREFORE, in consideration of the f]
[Execution Version SHARE REPURCHASE AGREEMENT Agreement This Share Repurchase Agreement (this (i) Company (ii) Selling Shareholder Party Parties Each of the parties listed above shall be referred to herein individually as a RECITALS WHEREAS SHA WITNESSETH NOW, THEREFORE, in consideration of the f]
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be]
